Table 2 Single nucleotide polymorphism (SNP) allele frequencies in patients with Wegener’s granulomatosis (WG) and controls
SNPRefSeq numberMajor/minor alleleCEU allele frequencies according to HapMapMAF in controlsMAF in patients with WG*p Value
1rs588997G/A0.64/0.360.370.340.198
26rs1367728G/A0.90/0.100.120.140.323
2rs9469341A/G0.88/0.120.160.080.0001
27rs9277341T/C0.78/0.220.280.136.01×10−10
3rs3117228C/A0.68/0.320.300.083.64×10−21
28rs2281390C/A0.84/0.160.180.230.030
4rs2064474C/T0.79/0.210.240.052.323×10−19
5rs3130215G/A0.56/0.440.41 (A)0.38 (G)1.946×10−13
29rs11751659A/G0.85/0.150.130.150.492
6rs3130233T/C0.51/0.490.500.390.0001
7rs3129269G/T0.65/0.350.370.263.35×10−5
8rs2294478G/T0.59/0.410.460.490.428
9rs2294477C/G0.59/0.410.44 (G)0.43 (C)4.72×10−6
10rs2294473G/C0.52/0.480.460.470.522
11rs9277882T/G0.62/0.380.440.340.0004
12rs7754362A/C0.69/0.310.430.340.0019
13rs3129208T/C0.55/0.450.370.480.0001
14rs9277916C/G0.69/0.310.320.300.283
15rs3116956G/A0.65/0.350.330.454.96×10−6
16rs734181G/C0.78/0.220.180.150.116
17rs1799910G/A0.55/0.450.490.317.71×10−10
18rs2855423C/T0.69/0.310.260.427.63×10−10
19rs9277934C/T0.70/0.300.310.280.276
20rs421446T/C0.74/0.260.270.143.78×10−9
32rs213210T/C0.94/0.060.060.010.0001
33rs213209G/A0.75/0.250.270.145.45×10−9
34rs213208C/A0.78/0.220.220.082.14×10−12
35rs2854028G/A0.77/0.230.230.220.779
21rs9277936T/A0.75/0.250.250.260.611
22rs213213G/A0.68/0.320.310.492.26×10−10
23rs213194A/G0.73/0.270.240.426.82×10−11
30rs9277952G/A0.64/0.360.110.070.0059
31rs460568G/A0.81/0.190.150.180.154
24rs213199C/T0.67/0.330.360.300.031
25rs213207A/G0.52/0.480.500.470.288
  • *MAF from patients with WG and p values are given for the entire cohort (n = 282). For differential data from the original patient cohort (Jagiello et al11), the new ANCA-positive cohort and the ANCA-negative cohort see supplementary table 1.

  • ANCA, antineutrophil cytoplasmic antibodies; MAF, minor allele frequency.